CD274 and small cell lung carcinoma: A meta‐analysis study of 2905 ES‐SCLCs, which included six previous studies, identified that the addition of PD‐1/PD‐L1 inhibitors to chemotherapy could result in favorable outcomes regarding the PFS and OS in ES‐SCLC FL treatment settings without additional AEs.29